BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4597736)

  • 1. Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.
    McCullough JL; Maren TH
    Antimicrob Agents Chemother; 1973 Jun; 3(6):665-9. PubMed ID: 4597736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.
    Ho RI; Corman L; Mores SA; Schneider H
    Antimicrob Agents Chemother; 1975 Jun; 7(6):758-63. PubMed ID: 808157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
    Merali S; Zhang Y; Sloan D; Meshnick S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1075-8. PubMed ID: 2203302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
    Seydel JK; Richter M; Wempe E
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):18-29. PubMed ID: 6988345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog.
    Swedberg G; Castensson S; Sköld O
    J Bacteriol; 1979 Jan; 137(1):129-36. PubMed ID: 368012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
    Thijssen HH
    J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.
    De Benedetti PG; Iarossi D; Folli U; Frassineti C; Menziani MC; Cennamo C
    J Med Chem; 1989 Oct; 32(10):2396-9. PubMed ID: 2677378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropteroate synthetase from Plasmodium berghei: isolation, properties, and inhibition by dapsone and sulfadiazine.
    McCullough JL; Maren TH
    Mol Pharmacol; 1974 Jan; 10(1):140-5. PubMed ID: 4602912
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.
    De Benedetti PG; Iarossi D; Menziani C; Caiolfa V; Frassineti C; Cennamo C
    J Med Chem; 1987 Mar; 30(3):459-64. PubMed ID: 3546688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
    Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
    J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified radioassay method of dihydropteroate synthetase activity in Escherichia coli and its application for an inhibition study of p-aminobenzoi acid derivatives.
    Thijssen HH
    Anal Biochem; 1973 Jun; 53(2):579-85. PubMed ID: 4577373
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-free dihydropteroate synthetase activity: its use to investigate the relationship between structure and activity of p-aminobenzoic derivatives.
    Thijssen HH
    Methods Enzymol; 1980; 66():570-6. PubMed ID: 6990197
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
    Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
    J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase.
    Roland S; Ferone R; Harvey RJ; Styles VL; Morrison RW
    J Biol Chem; 1979 Oct; 254(20):10337-45. PubMed ID: 385600
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of mafenide on dihydropteroate synthase.
    Eagon RG; McManus AT
    J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
    Lever OW; Bell LN; McGuire HM; Ferone R
    J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
    Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
    J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effectiveness with which p-aminobenzoic acid and p-aminobenzoylglutamic acid are used as substrate by dihydropteroate synthetase from Escherichia coli.
    Richey DP; Brown GM
    Biochim Biophys Acta; 1970 Oct; 222(1):237-9. PubMed ID: 4919883
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases.
    Wise EM; Abou-Donia MM
    Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2621-5. PubMed ID: 1101260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphanilic acid inhibits dihydropteroate synthase.
    Eagon RG; McManus AT
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1936-8. PubMed ID: 2514624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.